
Skin cancer research
Improving current melanoma therapies

Dr Su Yin (‘Esther’) Lim
Esther is a researcher at the Precision Cancer Therapy Group at Macquarie University. Her research is focused on melanoma – a common, aggressive form of skin cancer.
If not treated in its early stages, melanoma has a high mortality rate. Australia has the highest occurrence of this disease with diagnosis of around 14,000 new cases expected in 2017. Worldwide, approximately 132,000 cases are diagnosed each year.
Esther is determined to make a difference – and, she says, will do so “through persistence, tenacity and hard work”.
Dr Su Yin (Esther) Lim's research
Esther’s research looks for ways to boost the human immune system to improve the effectiveness of current melanoma therapies.
Specifically, she investigates inhibitors for a protein pathway in the body known as MAPK, which plays a key role in the development of melanoma.
Work in this field has already improved survival rates of the 30-40% of Australian patients who have a form of the disease known as BRAF-mutant melanoma.
“Outcomes of this project will translate rapidly into clinical practice, and will hopefully help improve patients’ lives,” she says.
Funding means progress
Cure Cancer Australia’s funding enables Esther to continue her research in this area. She describes it as “a massive encouragement for me to keep going.”
Esther believes that the biggest challenge for cancer medicine is that there’s so much research and work to be done, and never enough funding to support it in the way that it deserves.
“That’s why the Cure Cancer Australia grants are so important; they foster the progress of understanding a very difficult disease and the discovery of new treatments,” she says.
To cancer patients and their families, Esther has a message of hope: “We’ve made significant leaps in understanding this disease and all cancer researchers, including myself, are working very hard towards finding better treatments and, ultimately, a cure.”
Esther is funded by Cure Cancer Australia and Cancer Australia through the Cancer Australia Priority-Driven Collaborative Cancer Research Scheme. Her grant is solely supported by The Can Too Foundation
"We’ve made significant leaps in understanding this disease, and we're working very hard towards finding better treatments and, ultimately, a cure”.
Related Blog Posts

World Cancer Day: Meet Cure Cancer's 2025 researchers

Together, we’re creating breakthroughs: A look back at 202...

Multi-Omics 2024 and Cure Cancer's impact on innovation in c...

Lunch & Learn series
Find out about the latest developments in cancer research first hand from our researchers and the impact of your support.
We take on every cancer
Cure Cancer funds ground breaking research across every cancer, no matter the size or rarity.
We aim to maximise our impact, save millions of lives, and leaves no one behind.

Our research grant program
We are dedicated to funding new innovative cancer research projects, giving talented emerging cancer researchers the opportunity to pursue their innovative ideas across diverse areas of cancer research.
Through our Research Grants Program, we commit to back new ideas from the most brilliant minds in cancer research.
Let's stay in touch
To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.